HNN3.0
Register
Register
Register

Fondazione Italiana Fegato

R&D Institution

www.fegato.itTrieste, Italy
7 profile visits

About

At Fondazione Italiana Fegato, we are dedicated to advancing research and awareness around liver diseases in Italy and beyond. Our mission is to promote scientific studies, provide education, and support patients dealing with liver conditions. We collaborate with healthcare professionals, researchers, and institutions to drive innovation and enhance the quality of life for those affected. Together, we strive to foster a healthier future through our commitment to liver health and disease prevention.

Social media

Representatives

senior scientist

Fondazione Italiana Fegato

Senior researcher -MASLD UNit

Fondazione Italiana Fegato

Marketplace (2)

  • Project cooperation

    Metabolic Syndrome - Obesity- MASLD

    Fondazione Italiana Fegato (FIF) is a non-profit research organisation in Trieste, Italy. Its MASLD Unit investigates the mechanisms of liver disease, develops non-invasive biomarkers, and evaluates metabolic interventions for obesity and type 2 diabetes.

    • Partner seeks Consortium/Coordinator
    • Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
    • Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
    Author

    Senior researcher -MASLD UNit at Fondazione Italiana Fegato

    Trieste, Italy

  • Project cooperation

    Biomarkers on liver diseases by omics

    Fondazione Italiana Fegato is based in Italy, focused on translational hepatology. We study MASLD in the context of obesity, T2DM, and cardiometabolic conditions, with an emphasis on biomarker discovery, disease mechanisms, and response to interventions.

    • Partner seeks Consortium/Coordinator
    • Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
    • Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
    Author

    senior scientist at Fondazione Italiana Fegato

    Trieste, Italy